Dyadic International, Inc. Share Price
NASDAQ: DYAI | Micro CapDyadic International, Inc. Stock Performance
Open $1.02 | Prev. Close $1.00 | Circuit Range N/A |
Day Range $1.02 - $1.02 | Year Range $0.66 - $1.59 | Volume 1,932 |
Average Traded $1.02 |
Dyadic International, Inc. Share Price Today
As of 10 August 2026, Dyadic International, Inc.'s share price is $1.01. The stock opened at $1.02, compared to its previous close of $1.00. During today's trading session, Dyadic International, Inc.'s share price traded between $1.02 and $1.02, with an average price of $1.02. Over the past 52 weeks, the stock has recorded a high of $1.59 and a low of $0.66. In terms of performance, Dyadic International, Inc.'s share price has risen by 31.17% over the last six months and is up 7.56% on a year-on-year basis.
Dyadic International, Inc. Share Price Chart
Dyadic International, Inc. Stock Fundamentals & Key Indicators
Market Cap $32.95M | PE Ratio (TTM) -4.39 | Dividend Yield N/A |
EPS (TTM) $-0.23 | Revenue (TTM) $3.09M | Return On Equity (TTM) -597.58% |
Profit Margin -238.31% | Debt to Equity 2.99 | Quarterly Earnings Growth YoY -871.20% |
Dyadic International, Inc. Quarterly Profit & Loss
All figures in USD
Dyadic International, Inc. Annual Profit & Loss
All figures in USD
About Dyadic International, Inc.
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and large-scale manufacture of cost-effective enzymes, proteins, metabolites, and other biologic products for life sciences, food and nutrition, and bioindustrial applications. In addition, it develops DYAI-100, a C1-SARS-CoV-2 recombinant protein RBD vaccine candidate and first C1, which is in phase 1 clinical trial to produce protein tested in humans. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; joint development agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Dyadic International, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.05 | $1.02 | -4.23% |
Jul 2026 | $0.93 | $1.06 | +18.99% |
Jun 2026 | $0.79 | $0.90 | +12.58% |
May 2026 | $0.76 | $0.80 | +6.71% |
Apr 2026 | $0.85 | $0.74 | -14.37% |
Mar 2026 | $0.76 | $0.87 | +12.99% |
Feb 2026 | $0.85 | $0.77 | -13.58% |
Jan 2026 | $0.93 | $0.89 | -6.31% |
Dec 2025 | $1.07 | $0.95 | -1.45% |
Nov 2025 | $1.07 | $0.96 | -15.72% |
Oct 2025 | $1.22 | $1.15 | -3.78% |
Sep 2025 | $0.90 | $1.19 | +26.73% |
DYAI Share Price FAQs
What is Dyadic International, Inc. share price today?
What is the 52 week high and 52 week low of Dyadic International, Inc. stock?
What is DYAI's market capitalisation today?
What is DYAI's net income for the last quarter?
What is the 5 year returns of DYAI?
What is the high & low stock price of DYAI today?
Can I buy DYAI shares in India?